Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · AptarGroup (ATR)

AptarGroup CEO Stephan Tanda to retire; Gael Touya named CEO effective September 1, 2026

Neutral Impact 4 of 5 leadership Written later

AptarGroup said CEO Stephan Tanda will retire effective September 1, 2026, and its board has appointed Gael Touya, currently president of the Aptar Pharma segment, as successor CEO on that date. Tanda will stay on as strategic advisor and board member through December 31, 2026, to support the transition.

Key points

  • Gael Touya, age 56, has led the Pharma segment since September 2018 and is expected to join the board on the Effective Date
  • Touya's initial base salary is $1,060,000, with a 2026 target bonus of 120% of salary
  • Tanda will serve as strategic advisor through December 31, 2026, with a 2026 target short-term incentive of 130% of salary
  • Chief Financial Officer Vanessa Kanu and President Hedi Tlili each received restricted stock units with a grant date fair value of $1.3 million

The filing

CompanyAptarGroup (ATR)
Form8-K, current report
Filed with the SECMar 17, 2026, 5:23 PM ET
Accession number0001104659-26-029612

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:17 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 17, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.